RESUMEN
Mammalian olfaction and reproduction are tightly linked, a link less explored in humans. Here, we asked whether human unexplained repeated pregnancy loss (uRPL) is associated with altered olfaction, and particularly altered olfactory responses to body-odor. We found that whereas most women with uRPL could identify the body-odor of their spouse, most control women could not. Moreover, women with uRPL rated the perceptual attributes of men's body-odor differently from controls. These pronounced differences were accompanied by an only modest albeit significant advantage in ordinary, non-body-odor-related olfaction in uRPL. Next, using structural and functional brain imaging, we found that in comparison to controls, most women with uRPL had smaller olfactory bulbs, yet increased hypothalamic response in association with men's body-odor. These findings combine to suggest altered olfactory perceptual and brain responses in women experiencing uRPL, particularly in relation to men's body-odor. Whether this link has any causal aspects to it remains to be explored.
Asunto(s)
Aborto Habitual/fisiopatología , Hipotálamo , Trastornos del Olfato , Bulbo Olfatorio , Olfato/fisiología , Adulto , Femenino , Humanos , Hipotálamo/anatomía & histología , Hipotálamo/diagnóstico por imagen , Hipotálamo/metabolismo , Masculino , Odorantes/análisis , Trastornos del Olfato/diagnóstico por imagen , Trastornos del Olfato/fisiopatología , Bulbo Olfatorio/anatomía & histología , Bulbo Olfatorio/diagnóstico por imagen , Bulbo Olfatorio/metabolismo , Corteza Prefrontal/anatomía & histología , Corteza Prefrontal/diagnóstico por imagen , EmbarazoRESUMEN
The vitamin B12 status of infants depends on maternal B12 status during pregnancy, and during lactation if breastfed. We present a 9-month-old girl who was admitted to the metabolic unit for assessment of developmental delay. She was exclusively breastfed and the introduction of solids at 5 months was unsuccessful. Investigations revealed pancytopenia, undetectable B12 and highly elevated methylmalonic acid and homocysteine. Methylmalonic acid and homocysteine normalised following B12 injections. Marked catch-up of developmental milestones was noted after treatment with B12. Investigations of parents showed normal B12 in the father and combined B12 and iron deficiency in the mother. Maternal B12 deficiency, most likely masked by iron deficiency, led to severe B12 deficiency in the infant. Exclusive breastfeeding and a subsequent failure to wean exacerbated the infant's B12 deficiency leading to developmental delay. This case highlights the need for development of guidelines for better assessment of B12 status during pregnancy.
Asunto(s)
Anemia Ferropénica/diagnóstico , Lactancia Materna , Diagnóstico Tardío , Fenómenos Fisiológicos Nutricionales del Lactante , Fenómenos Fisiologicos Nutricionales Maternos , Estado Nutricional , Deficiencia de Vitamina B 12/diagnóstico , Aborto Habitual/fisiopatología , Adulto , Anemia Ferropénica/complicaciones , Anemia Ferropénica/dietoterapia , Anemia Ferropénica/etiología , Lactancia Materna/efectos adversos , Discapacidades del Desarrollo/etiología , Discapacidades del Desarrollo/prevención & control , Suplementos Dietéticos , Femenino , Compuestos Ferrosos/uso terapéutico , Hematínicos/administración & dosificación , Hematínicos/uso terapéutico , Humanos , Hidroxocobalamina/administración & dosificación , Hidroxocobalamina/uso terapéutico , Lactante , Inyecciones Intramusculares , Pancitopenia/etiología , Embarazo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 12/tratamiento farmacológico , Deficiencia de Vitamina B 12/fisiopatologíaRESUMEN
Selenium is an essential trace mineral required for normal human health and reproduction. In recent years selenium deficiency in humans has been implicated as a risk factor for recurrent pregnancy loss. So far the selenium status in recurrent pregnancy loss (RPL) has been evaluated only in plasma and serum samples showing discrepancies of selenium deficiency as a cause for RPL. The present pilot study from India has evaluated selenium status in red cells (as they are the better indicators of selenium levels) in 20 women with three or more unexplained recurrent pregnancy losses compared to similar number of controls. The mean+/-SD red cell selenium levels in the study group was found to be 119.55+/-32.94 ng/ml (range 55-170 ng/ml), which was significantly lower compared to the control group with a mean+/-SD of 150.85+/-37.63 ng/ml (range 87-225 ng/ml). The difference was statistically significant at the 1% level ( P <0.01). Since selenium supplementation resulted in successful pregnancy outcome in veterinary practice, we conclude that large randomised studies are needed to assess the contribution of selenium in the aetiology of RPL and the potential benefits of its supplementation.